Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Infinity Pharmaceuticals provides update on IPI-926 trials

Oct. 18, 2011

Novel autotaxin inhibitors designed by Merck KGaA

Oct. 18, 2011

ABI-007 advances through trial in gastric cancer

Oct. 18, 2011

First-in-patient study assesses EMD-525797 in metastatic CRPC

Oct. 18, 2011

Results made available from MENZA trial of enzastaurin

Oct. 18, 2011

Epizyme triggers milestone payment in HMT therapeutic alliance with GSK

Oct. 17, 2011

Dana-Farber Cancer Institute claims new protein kinase inhibitors

Oct. 17, 2011

Cylene Pharmaceuticals advances CX-5461

Oct. 17, 2011

Phase I trials assess efatutazone in Japanese and Korean patients with advanced solid tumors

Oct. 17, 2011

DSMB recommends continuing Cyclacel's SEAMLESS trial

Oct. 14, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...